Used primarily in organic synthesis, this compound serves as a key intermediate in the development of pharmaceuticals, particularly in the creation of kinase inhibitors. Its boronate ester group is crucial for Suzuki-Miyaura cross-coupling reactions, enabling the formation of carbon-carbon bonds in complex molecules. This makes it valuable in the production of targeted therapies for diseases such as cancer. Additionally, its urea moiety can enhance binding affinity to biological targets, improving drug efficacy. The methoxyphenyl group further contributes to the compound's stability and solubility, aiding in the optimization of drug-like properties.